<DOC>
	<DOCNO>NCT02897908</DOCNO>
	<brief_summary>The primary goal study establish database people vary level hepatic fibrosis various etiology liver disease use future research protocol .</brief_summary>
	<brief_title>Non-invasive Liver Screening Using FibroScan Device Liver Disease Patients Steatosis/Fibrosis Database</brief_title>
	<detailed_description>The Fibroscan device determine liver stiffness well amount fat another application machine call controlled attenuation parameter Controlled Attenuation Parameters ( CAP ) . The liver stiffness measurement translate score tell much liver fibrosis fat present . Patients identified potential fatty liver specific liver-related disease cause fibrosis would approach voluntary FibroScan measurement . From patient , investigator collect information relate demographic , disease history , medical comorbidities , social history , laboratory radiologic parameter . This information , along clinical data associate patient place database use identify potential subject future trial .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Subjects know , suspect risk factor steatosis ( fat ) hepatic fibrosis Subjects previously diagnose NonAlcoholic Steatohepatitis ( NASH ) current steatosis ( fat ) fibrosis score Subjects know liver disease ie : HCV Patients le 18 year age Pregnancy Patients want contact consideration future research study . Patients diagnosed ascites peritoneal dialysis Body mass index ( BMI ) â‰¥40</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>